Project Grant HT94252510319
Award Date
4/15/25
Completion Date
4/14/29
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richardson, TX 75080, USA
Similar Awards
This three-year Project Grant from the Defense Health Agency, totaling $847,194, will support research on "BIOMARKERS OF HYPERACUSIS IN AUTISM SPECTRUM DISORDER" at the University of Texas at Dallas from September 2023 through September 2026. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health...
The University of Texas at Dallas (UTD) was awarded a $2,744,321 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a culturally and linguistically sensitive intervention to alleviate core social challenges for young Hispanic autistic children. The award spans the period from September 1, 2024 to August 31, 2028. The project aims to meet the needs of this targeted population by creating an evidence-based...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $451,000.00 to the University of Texas Southwestern Medical Center to conduct research on "DISSECTING BIOLOGICAL MECHANISMS UNDERLYING BEHAVIORAL HETEROGENEITY IN AUTISM" from April 1, 2024 to March 31, 2027. The research aims to advance scientific understanding of the biological basis for the variability in autism spectrum disorder symptoms and...
The U.S. Department of the Army Medical Command awarded a $1,971,504 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to the University of Central Florida Board of Trustees Office of Research. The grant, awarded on April 15, 2025, will fund a 4-year crossover randomized controlled trial (RCT) to study the effectiveness of an individualized progressive treatment for expanding sound tolerance in adults with autism spectrum disorder. The research...
The Defense Health Agency awarded a $863,500 Project Grant to Rutgers, The State University of New Jersey under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 1, 2022 will support research into "Genetically Distinct ASD Subtypes: Is MTOR Dysregulation a Common Mechanism?" Through this funding, Rutgers researchers will investigate potential connections between mutations in the MTOR gene pathway and autism...
This $3,149,863 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a 4-year evaluation of tele-assessment services for autism spectrum disorder (ASD) in underserved communities. The award was made to Vanderbilt University Medical Center (VUMC), a nonprofit academic medical center in Nashville, Tennessee that has extensive experience supporting federal biomedical research and healthcare initiatives through...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
The University of Texas at Dallas (UTD) was awarded a $701,946 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 1, 2024, will support research to "TARGET MNK SIGNALING TO PREVENT AND REVERSE CHRONIC PAIN CAUSED BY COMPLEX TRAUMATIC INJURY" over a 4-year period ending on August 31, 2028. As a leading research university, UTD will leverage its expertise in areas such as...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $737,899.00 in funding to The University of Texas Health Science Center at San Antonio (UTHSCSA) to conduct nontrauma intervention research to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The three-year project, commencing on September 1, 2024 and scheduled for completion by August...
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...